Review article: The therapy of constipation

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 6, 2001, Pages 749-763

  Schiller, L R ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETHANECHOL; BILE ACID; BISACODYL; CARBOXYMETHYLCELLULOSE; CASCARA SAGRADA; CISAPRIDE; COLCHICINE; DOCUSATE SODIUM; GLYCEROL; ISPAGULA; LACTULOSE; LAXATIVE; LUBRICATING AGENT; MACROGOL; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MAGNESIUM SULFATE; MANNITOL; METHYLCELLULOSE; MINERAL OIL; MISOPROSTOL; MUSCLE RELAXANT AGENT; NEOSTIGMINE; OPIATE ANTAGONIST; OSMOTIC AGENT; PHENOLPHTHALEIN; PICOSULFATE SODIUM; POLYCARBOPHIL; POTASSIUM SODIUM TARTRATE; PRUCALOPRIDE; RICINOLEIC ACID; SENNA EXTRACT; SODIUM DIHYDROGEN PHOSPHATE; SODIUM SULFATE; SORBITOL; TEGASEROD; UNCLASSIFIED DRUG;

ANUS DISEASE; COLON LAVAGE; CONSTIPATION; DEFECATION; DIET; DIETARY FIBER; ENDOCRINE DISEASE; FEEDBACK SYSTEM; GASTROINTESTINAL MOTILITY; HUMAN; IATROGENIC DISEASE; INTESTINE INNERVATION; INTESTINE OBSTRUCTION; INTESTINE SECRETION; INTOXICATION; METABOLIC DISORDER; NEUROLOGIC DISEASE; OSMOSIS; PRIORITY JOURNAL; RECTUM DISEASE; REVIEW;

BIOFEEDBACK (PSYCHOLOGY); CATHARTICS; COLON; CONSTIPATION; FLUID THERAPY; GASTROINTESTINAL MOTILITY; HUMANS; IRRIGATION; LUBRICATION; NEUROMUSCULAR AGENTS;

EID: 0034993520     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00982.x     Document Type: Review

References (133)

1. A comparison of stool characteristics from normal and constipated people
2. Dietary fiber and personality factors as determinants of stool output
3. A longitudinal survey of self-reported bowel habits in the United States
4. Straining at stool and laxative taking in an English population
5. Constipation
6. Clinical management of intractable constipation
7. Cathartics, laxatives, and lavage solutions
8. The relationships between colonic motility and transport
9. Effects of laxative and nonlaxative hydrophilic polymers on canine small intestinal motor activity
10. Motor activity in the large intestine of the pig related to dietary fibre and retention time
11. Influence of α-cellulose on myoelectric activity of proximal canine colon
12. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation
13. Water-holding by dietary fibre in vitro and its relationship to fecal output in man
14. Wheat fiber and laxation: Dose response and equilibration time
15. Bulk laxative efficacy of a psyllium seed hydrocolloid and of a mixture of cellulose and pectin
16. Correlation between echographic gastric emptying and appetite: Influence of psyllium
17. Asthma from psyllium in laxative manufacture
18. Experimental assessment of the allergenicity of a psyllium-containing laxative
19. Workplace allergenicity of a psyllium-containing bulk laxative
20. Ispaghula sensitization in workers manufacturing a bulk laxative
21. Anaphylaxis following ingestion of a psyllium-containing cereal
22. Psyllium-induced asthma: Occupational exposure in a nurse
23. Clinical evaluation of methylcellulose as a bulk laxative
24. Clinical response to dietary fiber treatment of chronic constipation
25. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose
26. Carbohydrate malabsorption: Its measurement and its contribution to diarrhea
27. Diagnosis of magnesium-induced diarrhea
28. Intestinal absorption of magnesium from food and supplements
29. Absorption of orally administered sodium sulfate in humans
30. Investigation and diagnosis of diarrhea caused by sodium phosphate
31. Single-day, divided-dose oral sodium phosphate laxative versus intestinal lavage as preparation for colonoscopy: Efficacy and patient tolerance
32. Cleansing ability and tolerance of three bowel preparations for colonoscopy
33. Cost-effective treatment of constipation in the elderly: A randomized double-blind comparison of sorbitol and lactulose
34. Osmotic effects of polyethylene glycol
35. Development of a lavage solution associated with minimal water and electrolyte absorption or secretion
36. A low-sodium solution for gastrointestinal lavage
37. Randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative
38. Clinical subgroups of chronic constipation: Exploring the potential of polyethylene glycol
39. Use of low dose polyethylene glycol solutions in the treatment of functional constipation
40. Effect of dioctyl sodium sulfosuccinate on structure and function of rodent and human intestine
41. Studies on the mechanism of action of dioctyl sodium sulphosuccinate in the human jejunum
42. Dioctyl sodium suffosuccinate: An ineffective prophylactic laxative
43. Constipation prevention: Empiric use of stool softeners questioned
44. Cholic acid therapy for constipation: A controlled study
45. Enterohepatic circulation, urinary excretion and laxative action of some bisacodyl derivatives after intragastric administration in the rat
46. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: A possible mechanism for carcinogenicity
47. US to ban sale of many laxatives over the counter (news)
48. Effect of bisacodyl on the structure and function of rodent and human intestine
49. Is bisacodyl absorbed at all from suppositories in man?
50. Bis-(p-hydroxyphenyl)-pryidyl-2-methane: The common laxative principle of bisacodyl and sodium picosulfate
51. A new oral bowel evacuant (Picolax) for colon cleansing
52. Washout versus non-washout (Picolax) preparation for double-contrast barium enemas
53. Quantitative appraisal of Picolax (sodium picosulfate/magnesium citrate) in the preparation of the large bowel for elective surgery
54. Ricinoleic acid stimulation of active anion secretion in colonic mucosa of the rat
55. Interaction of laxatives with enzymes of cyclic AMP metabolism from human colonic mucosa
56. Inhibition of water absorption by ricinoleic acid: Evidence against hormonal mediation of the effect
57. A unique distribution of laxative-induced spike potentials from the small intestine of the dog
58. Effects of oral laxatives on colonic motor complexes in dogs
59. Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon
60. Some aspects of the pharmacology of anthraquinone drugs
61. Senna and its rational use
62. Metabolism of sennosides and rhein in the rat
63. Metabolism of barbaloin by intestinal bacteria
64. Effect of rhein on the transport of electrolytes, water, and carbohydrates in the human jejunum and colon
65. Review article: Anthranoid laxatives and their potential carcinogenic effects
66. Finger clubbing associated with laxative abuse
67. Melanosis of the rectum in patients with chronic constipation
68. Melanosis coli: Ultrastructural study of 45 patients
69. Melanosis coli: A consequence of anthraquinone-induced apoptosis of colonic epithelial cells
70. The pigment of Melanosis coli: A lectin histochemical study
71. Melanosis coli - A harmless pigmentation or a precancerous condition?
72. The role of chronic constipation, diarrhea, and laxative use in the etiology of large-bowel cancer
73. Influence of a highly purified senna extract on colonic epithelium
74. Anthranoid laxatives and colorectal cancer
75. Anthranoid laxative use is not a risk factor for colorectal neoplasia: Results of a case control study
76. Does senna extract promote growth of aberrant crypt foci and malignant tumors in rat colon?
77. Effect of irritant purgatives on the myenteric plexus in man and the mouse
78. The fine structure of colonic submucosal nerves in patients with chronic laxative abuse
79. Ultrastructural changes in the gut autonomic nervous system following laxative abuse and in other conditions
80. Ultrastructure of mouse intestinal mucosa and changes observed after long term anthraquinone administration
81. Cathartic colon
82. What has happened to the cathartic colon?
83. The use of bethanechol chloride with tricyclic antidepressants
84. Neostigmine for the treatment of acute colonic pseudo-obstruction
85. Treatment of acute colonic pseudo-obstruction with neostigmine
86. Drugs affecting serotonin receptors
87. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor
88. Cisapride for the treatment of constipation in children: A double-blind study
89. Cisapride in the management of chronic pediatric constipation
90. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome
91. The risk of serious cardiac arrhythmias aming cisapride users in the United Kingdom and Canada
92. Reduced access to gastric motility drug will not sit well with many physicians or patients
93. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers
94. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans
95. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
96. Misoprostol in the treatment of chronic refractory constipation: Results of a long-term open label trial
97. Misoprostol is effective treatment for patients with severe chronic constipation
98. Colchicine is an effective treatment for patients with chronic constipation: An open-label trial
99. Use of colchicine to treat constipation in developmentally disabled patients
100. Naloxone, a specific opiod antagonist, reverses chronic idiopathic constipation
101. Idiopathic slow-transit constipation: Whole gut transit times, measured by a new simplified method, are not shortened by opiod antagonists
102. Oral naloxone reverses opioid-associated constipation
103. Methylnaltrexone for reversal of constipation due to chronic methadone use: A randomized controlled trial
104. The use of gastrointestinal drugs during pregnancy and lactation
105. Biofeedback treatment of constipation: A comparison of two methods
106. Clinical and physiologic effects of biofeedback in outlet obstruction constipation
107. Biofeedback training in disordered defecation. A critical review
108. Biofeedback training is useful in fecal incontinence but disappointing in constipation
109. Initial North American experience with botulinum toxin type A for treatment of anismus
110. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome
111. Operative management of severe constipation
112. Outcome of colectomy for slow-transit constipation
113. Should patients with combined colonic inertia and nonrelaxing pelvic floor undergo subtotal colectomy?
114. Long-term results of surgery for chronic constipation
115. Long-term results of subtotal colectomy and evidence of noncolonic involvement in patients with idiopathic slow-transit constipation
116. Selection of constipated patients as subtotal colectomy candidates
117. Current preoperative bowel cleansing methods: Results of a survey
118. Preparing the colon for the barium enema examination
119. Comparison of colon cleansing methods in preparation for colonoscopy
120. A physiological appraisal of polyethylene glycol and a balanced electrolyte solution as bowel preparation
121. Mechanical preparation of the large bowel for elective surgery: Comparison of whole-gut lavage with the conventional enema and purgative technique
122. Colon cleansing: Acceptance by older patients
123. A new oral lavage solution vs. cathartics and enema method for preoperative colonic cleansing
124. Comparison of two oral evacuants (Citromag and Golytely) for bowel preparation before barium enema
125. Improvements in mechanical bowel preparation for elective colorectal surgery
126. Randomized, controlled comparison of two forms of preparation for screening flexible sigmoidoscopy
127. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose
128. Drug overdose: Reducing the load
129. Gastrointestinal decontamination: Which method is best?
130. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal
131. Gastrointestinal decontamination for acute poisoning by ingestion. Prevention of absorption of toxic compounds
132. An in vitro evaluation of fluoxetine adsorption by activated charcoal and desorption upon addition of polyethylene glycol-electrolyte lavage solution